| Net Cash Provided by (Used in) Operating Activities |
$13,955,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$793,784,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$674,683,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares Authorized |
40,000,000 |
shares |
-80% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$105,146,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$109,069,000 |
USD |
2798% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,987,040 |
USD |
121% |
Q4 2024 |
FY 2024 |
| Depreciation |
$1,068 |
USD |
|
Q1 2024 |
Q1 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$13,559 |
USD |
-52% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,987,040 |
USD |
121% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
21,000,000,000 |
shares |
41900% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,047,185,000 |
USD |
8327% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$12,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$16,300,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |